Top Markets
Coin of the day
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Rangering i aksjer #26470
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Aksjekurs
$2.69
Markedsverdi
$40.34M
Endring (1 dag)
-1.47%
Endring (1 år)
-48.27%
Land
US
Handel Serina Therapeutics, Inc. (SER)

Kategori

Historikk for aksjesplitt for Serina Therapeutics, Inc. (SER)
Aksjen Serina Therapeutics, Inc. (symbol: SER) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 20, 2026.
Én SER-aksje kjøpt før Aug 20, 2026 tilsvarer i dag 0 SER-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US